These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 4117647)

  • 1. [Modern treatment of parkinsonism].
    Birkmayer W; Neumayer E
    Z Neurol; 1972; 202(4):257-80. PubMed ID: 4117647
    [No Abstract]   [Full Text] [Related]  

  • 2. The balance of biogenic amines as condition for normal behaviour.
    Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    J Neural Transm; 1972; 33(2):163-78. PubMed ID: 4643007
    [No Abstract]   [Full Text] [Related]  

  • 3. Levodopa in Parkinsonism.
    Weiss JL; Chase TN
    Drugs; 1971; 2(4):257-61. PubMed ID: 4948349
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic supersensitivity in parkinsonism.
    Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    Adv Neurol; 1975; 9():121-9. PubMed ID: 1146650
    [No Abstract]   [Full Text] [Related]  

  • 5. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W
    Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
    Schneider E; Fischer PA; Jacobi P; Maxion H
    Arch Psychiatr Nervenkr (1970); 1973 Mar; 217(1):95-112. PubMed ID: 4695662
    [No Abstract]   [Full Text] [Related]  

  • 7. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
    [No Abstract]   [Full Text] [Related]  

  • 8. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E
    Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
    [No Abstract]   [Full Text] [Related]  

  • 9. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
    Miller EM; Wiener L
    Neurology; 1974 May; 24(5):482-6. PubMed ID: 4857107
    [No Abstract]   [Full Text] [Related]  

  • 10. Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.
    Chase TN; Watanabe AM
    Neurology; 1972 Apr; 22(4):384-92. PubMed ID: 5062828
    [No Abstract]   [Full Text] [Related]  

  • 11. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
    Fahn S
    Neurology; 1974 May; 24(5):431-41. PubMed ID: 4857104
    [No Abstract]   [Full Text] [Related]  

  • 12. [L-tryptophan therapy of DOPA psychoses].
    Birkmayer W; Neumayer E
    Nervenarzt; 1972 Feb; 43(2):76-8. PubMed ID: 4501978
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinsonism, levodopa, and anesthesia.
    Ngai SH
    Anesthesiology; 1972 Sep; 37(3):344-51. PubMed ID: 4559395
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK
    Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
    [No Abstract]   [Full Text] [Related]  

  • 15. L-dopa in the treatment of parkinsonism.
    Haleem MA
    Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of parkinsonism with levo-dopa: results in 302 cases.
    Newkirk TA; Magee KR
    Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
    Dupont E; Hansen E; Melsens S; Parkenberg H; Holm P
    Acta Neurol Scand Suppl; 1972; 51():115-7. PubMed ID: 4514334
    [No Abstract]   [Full Text] [Related]  

  • 18. Start hesitation--a side effect of long-term levodopa therapy.
    Ambani LM; Van Woert MH
    N Engl J Med; 1973 May; 288(21):1113-5. PubMed ID: 4697941
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of parkinsonism. Current concepts.
    Yahr MD
    Med Clin North Am; 1972 Nov; 56(6):1377-92. PubMed ID: 4117524
    [No Abstract]   [Full Text] [Related]  

  • 20. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R; de Ajuriaguerra J
    Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.